LLS | The Financial Burden of Blood Cancer Treatment for Working-Aged Adults is Growing
A recent study shows working-aged adults diagnosed with cancer—especially a blood cancer like lymphoma—have a growing financial burden, even with insurance.
Related Articles
Why Are There So Many Heart Attacks on Christmas? Beware: Joel Kahn, MD: Integrative Cardiologist
Heart attacks and strokes surge during the last two weeks of December, according to the American Heart Association, with Dec. 25 being the day of…
Nobel Prizes 2024: Celebrating artificial intelligence
This year’s Nobel Prizes underscore the transformative impact of the artificial intelligence revolution currently underway, with notable connections to the achievements recognized in physics and chemistry
Bryan Johnson’s shocking anti-aging journey in Netflix’s new documentary | Watch | Today News
In Don’t Die: The Man Who Wants to Live Forever, Bryan Johnson shares his radical anti-aging regimen, including gene therapy and plasma exchanges, to live…
Drinking more coffee linked to reduced cognitive decline in people with atrial fibrillation
Drinking multiple cups of coffee a day may help prevent cognitive decline in people with atrial fibrillation (AFib or AF), according to new research published…
FDA Finalizes Updated “Healthy” Nutrient Content Claim
FDA has issued a final rule to update the “healthy” nutrient content claim to help consumers identify foods that are particularly useful as the foundation…
Atypical Chronic GVHD: CNS Disease | Cancer Nursing Today
Oncology nurses caring for patients with acute or cGVHD need to understand CNS involvement to empower patients and caregivers for early recognition and reporting.
This Plant-Based Protein is a Great Addition to Any Runner’s Diet
Should shake up your diet with this plant protein? A sports dietitian gives us the scoop.
Initial Efficacy, Safety Results Reported for PTCL TRBC1-Directed CAR T-Cell Therapy | Blood Cancers Today
Limitations on benefits from immunotherapy in this setting increase clinical interest in this CAR T-cell therapy approach.
FDA Grants Breakthrough Therapy Designation to Sacituzumab Govitecan for ES-SCLC | Docwire News
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to sacituzumab govitecan-hziy (Trodelvy®) for extensive-stage small cell lung cancer.
Excess Mortality and Hospitalizations Associated With Seasonal Influenza in Patients With Heart Failure:
AbstractBackgroundInfluenza virus may cause severe infection in patients with heart failure. It is known that influenza infection is associated with increased morbidity and mortality in…
